Recent studies revealed that PD-L1 expression on tumor cells might predict poor prognosis in most epithelial-originated cancers [30], suggesting an effect of PD-L1 on inducing tumor progression through regulation of antitumor immunity [31]. The gene discussed is CD274; the disease is neoplasm.